Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Res. 1992 Oct 1;52(19 Suppl):5465s-5467s.

Primary immunodeficiencies: genetic risk factors for lymphoma.

Author information

  • 1Immunodeficiency Cancer Registry, University of Minnesota, Minneapolis 55455.

Abstract

It has been estimated that up to 25% of patients with certain genetically determined immunodeficiencies will develop tumors, primarily B-cell lymphomas, during their lifetime. Epstein-Barr virus appears to be an important cofactor in the development of lymphoproliferative disorders in patients with primary immunodeficiencies, as well as acquired immunodeficiencies. Additionally, host defects in immunoregulation and/or gene rearrangement, which are features of certain primary immunodeficiencies, probably contribute to the risk of lymphomagenesis in patients at risk.

PMID:
1327508
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk